| __timestamp | HUTCHMED (China) Limited | Takeda Pharmaceutical Company Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 91813000 | 1777824000000 |
| Thursday, January 1, 2015 | 178203000 | 1807378000000 |
| Friday, January 1, 2016 | 216080000 | 1732051000000 |
| Sunday, January 1, 2017 | 241203000 | 1770531000000 |
| Monday, January 1, 2018 | 214109000 | 2097224000000 |
| Tuesday, January 1, 2019 | 204890000 | 3291188000000 |
| Wednesday, January 1, 2020 | 227976000 | 3197812000000 |
| Friday, January 1, 2021 | 356128000 | 3569006000000 |
| Saturday, January 1, 2022 | 426409000 | 4027478000000 |
| Sunday, January 1, 2023 | 837999000 | 4263762000000 |
| Monday, January 1, 2024 | 4263762000000 |
Cracking the code
In the ever-evolving pharmaceutical landscape, revenue performance is a key indicator of a company's market position and growth potential. Over the past decade, Takeda Pharmaceutical Company Limited and HUTCHMED (China) Limited have showcased contrasting trajectories. Takeda, a Japanese powerhouse, has consistently demonstrated robust revenue growth, peaking at approximately $4.26 trillion in 2023, marking a 140% increase since 2014. In contrast, HUTCHMED, a rising star from China, has seen its revenue grow by over 800% during the same period, reaching $838 million in 2023. This stark difference highlights Takeda's established market dominance and HUTCHMED's rapid ascent in the industry. While Takeda's revenue figures dwarf those of HUTCHMED, the latter's impressive growth rate signals its potential to become a formidable player in the global pharmaceutical arena. Missing data for 2024 suggests an opportunity for further analysis and insights.
Revenue Showdown: AstraZeneca PLC vs Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited and Exelixis, Inc.: A Comprehensive Revenue Analysis
Takeda Pharmaceutical Company Limited vs Ionis Pharmaceuticals, Inc.: Annual Revenue Growth Compared
Comparing Revenue Performance: Takeda Pharmaceutical Company Limited or Merus N.V.?
Takeda Pharmaceutical Company Limited or HUTCHMED (China) Limited: Who Invests More in Innovation?
Takeda Pharmaceutical Company Limited and Novavax, Inc.: A Comprehensive Revenue Analysis
Revenue Insights: BeiGene, Ltd. and HUTCHMED (China) Limited Performance Compared
Annual Revenue Comparison: BioMarin Pharmaceutical Inc. vs HUTCHMED (China) Limited
Breaking Down Revenue Trends: Walgreens Boots Alliance, Inc. vs HUTCHMED (China) Limited
Vericel Corporation or HUTCHMED (China) Limited: Who Leads in Yearly Revenue?
Revenue Showdown: HUTCHMED (China) Limited vs Supernus Pharmaceuticals, Inc.
Who Generates More Revenue? HUTCHMED (China) Limited or Travere Therapeutics, Inc.